Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation
International Journal of Molecular Sciences · 18.08.2025 · 26 (16) · 7968
DOI: 10.3390/ijms26167968 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2025. Verfasst von Lucila A Godínez-Méndez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Oligosaccharides, Colitis, Ulcerative, Anti-Inflammatory Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the (1.1.2) 260699 Programa de Impulso a la Investigación 2020, the Programa de Apoyo a la Mejora en las Condiciones de Producción de los Miembros del SNI, the Estancias Posdoctorales por México 2022 program.
Abstract (Originalsprache)
Ulcerative colitis is a chronic inflammatory bowel disease characterized by persistent inflammation, immune dysregulation, gut microbiota alterations, and impaired epithelial barrier function. Lupinus albus is a legume rich in galactooligosaccharides (GOS) that functions as a prebiotic capable of modulating the gut microbiota and mitigating ulcerative colitis-related damage. This study aimed to elucidate the effect of GOS on gut microbiota modulation and the molecular mechanisms involved in epithelial restoration and inflammation reduction. Fifteen C57BL/6 mice were randomly assigned to three groups (n = 5 per group): control (CTL), ulcerative colitis (UC), and ulcerative colitis + GOS (UC + GOS). UC was induced by administering 2% dextran sulfate sodium (DSS) in drinking water for seven days. The UC + GOS group received 2.5 g/kg BW of GOS via gavage for 14 days. GOS administration improved mucus layer thickness, regulated the expression of tight junction proteins, reduced pro-inflammatory cytokine levels, and modulated the gut microbiota, preventing the loss of richness and diversity. Additionally, the expression of monocarboxylate transporters (MCTs) MCT1 and MCT4 was evaluated, and significant differences were observed between the groups across colon and cecum tissues. These findings suggest that GOS supplementation may play a potential role in attenuating ulcerative colitis by regulating the gut microbiota and the metabolic state of intestinal cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
- Departamento Académico de Ciencias Básicas, Universidad Autónoma de Guadalajara, Av. Patria 120, Zapopan 45129, Mexico.
- Laboratorio de Diagnóstico en Enfermedades Emergentes y Reemergentes (LADEER), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
- Laboratorio de Investigación en Cáncer e Infecciones (LICI), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
- Laboratorio de Investigación y Desarrollo Farmacéutico (LIDF), Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Mexico.
- Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
ORCID-Profile: Lucila A Godínez-Méndez, Alejandra Natali Vega-Magaña, Marcela Peña-Rodríguez, Germán Muñoz-Sánchez, Rocío López-Roa, Martha Eloisa Ramos-Márquez, Mary Fafutis-Morris
Förderung
- the (1.1.2) 260699 Programa de Impulso a la Investigación 2020
- the Programa de Apoyo a la Mejora en las Condiciones de Producción de los Miembros del SNI
- the Estancias Posdoctorales por México 2022 program
Zitieren
APA
Godínez-Méndez, L. A., Vega-Magaña, A. N., Peña-Rodríguez, M., Valencia-Hernández, G. A., Muñoz-Sánchez, G., Iñiguez-Gutiérrez, L., López-Roa, R., Ramos-Márquez, M. E., Fafutis-Morris, M., & Delgado-Rizo, V. (2025). Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation. International Journal of Molecular Sciences, 26(16), 7968. https://doi.org/10.3390/ijms26167968
Vancouver
Godínez-Méndez LA, Vega-Magaña AN, Peña-Rodríguez M, Valencia-Hernández GA, Muñoz-Sánchez G, Iñiguez-Gutiérrez L, et al. Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation. International Journal of Molecular Sciences. 2025;26(16):7968. doi:10.3390/ijms26167968
BibTeX
@article{GodnezMndez2025,
author = {Godínez-Méndez, Lucila A and Vega-Magaña, Alejandra Natali and Peña-Rodríguez, Marcela and Valencia-Hernández, Gisela Anay and Muñoz-Sánchez, Germán and Iñiguez-Gutiérrez, Liliana and López-Roa, Rocío and Ramos-Márquez, Martha Eloisa and Fafutis-Morris, Mary and Delgado-Rizo, Vidal},
title = {Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {16},
pages = {7968},
doi = {10.3390/ijms26167968}
}
EUVIMED